CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: A case control study

BMC Cancer

Volumn 10, Issue , 2010, Pages

  San Jose, Carmen ^a   Cabanillas, Agustin ^a   Benitez, Julio ^b   Carrillo, Juan A ^b   Jimenez, Mercedes ^b   Gervasini, Guillermo ^b  

^a Merida Hospital   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CYTOCHROME P450 1A1; CYTOSINE; GENOMIC DNA; ISOLEUCINE; PROTEIN MSPI; THREONINE; THYMINE; TUMOR PROTEIN; UNCLASSIFIED DRUG; VALINE; DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PROTEIN LOCALIZATION; SEX DIFFERENCE; SPAIN; ADENOCARCINOMA; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INCIDENCE; LARGE CELL CARCINOMA; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SMALL CELL LUNG CARCINOMA; SMOKING; SPAIN;

EID: 77956854682     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-463     Document Type: Article

References (44)

1. Sanchez de Cos Escuin J, Riesco Miranda JA, Anton Martinez J, Diaz Santamaria P, Marquez Perez L, Medina Gallardo JF, Tapia Regidor JC, Rodriguez Blanco I. [Incidence of bronchopulmonary carcinoma in Extremadura in 1998]. Arch Bronconeumol 2000, 36(7):381-384.
2. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002, 3(8):461-469. 10.1016/S1470-2045(02)00815-X, 12147432.
3. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991, 4(4):391-407. 10.1021/tx00022a001, 1912325.
4. Gelboin HV. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 1980, 60(4):1107-1166.
5. Guengerich FP. Metabolic activation of carcinogens. Pharmacol Ther 1992, 54(1):17-61. 10.1016/0163-7258(92)90050-A, 1528954.
6. Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH, Guengerich FP. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 1992, 41(5):856-864.
7. Bartsch H, Petruzzelli S, De Flora S, Hietanen E, Camus AM, Castegnaro M, Alexandrov K, Rojas M, Saracci R, Giuntini C. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients. Environ Health Perspect 1992, 98:119-124. 10.2307/3431257, 1519605, 1336722.
8. McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 1990, 82(16):1333-1339. 10.1093/jnci/82.16.1333, 2380990.
9. Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 1982, 42(12):5030-5037.
10. Cuzick J, Routledge MN, Jenkins D, Garner RC. DNA adducts in different tissues of smokers and non-smokers. Int J Cancer 1990, 45(4):673-678. 10.1002/ijc.2910450417, 2323844.
11. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 1990, 46(4):569-575. 10.1002/ijc.2910460403, 2210880.
12. Anttila S, Vainio H, Hietanen E, Camus AM, Malaveille C, Brun G, Husgafvel-Pursiainen K, Heikkila L, Karjalainen A, Bartsch H. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ Health Perspect 1992, 98:179-182. 10.2307/3431265, 1519621, 1336724.
13. Anttila S, Hietanen E, Vainio H, Camus AM, Gelboin HV, Park SS, Heikkila L, Karjalainen A, Bartsch H. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer 1991, 47(5):681-685. 10.1002/ijc.2910470509, 1848536.
14. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001, 10(12):1239-1248.
15. Georgiadis P, Topinka J, Vlachodimitropoulos D, Stoikidou M, Gioka M, Stephanou G, Autrup H, Demopoulos NA, Katsouyanni K, Sram R, et al. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations. Carcinogenesis 2005, 26(1):93-101. 10.1093/carcin/bgh294, 15459023.
16. Schwarz D, Kisselev P, Cascorbi I, Schunck WH, Roots I. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 2001, 22(3):453-459. 10.1093/carcin/22.3.453, 11238186.
17. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, Yang IA, Bowman RV, Fong KM. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J 2010, 35(1):152-159. 10.1183/09031936.00120808, 19608585.
18. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, Kiyohara C, Min S, Lan Q, Le Marchand L, Lin P, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 2008, 17(5):1120-1126. 10.1158/1055-9965.EPI-07-2786, 18463401.
19. Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML, Garte S, Haugen A, Ingelman-Sundberg M, Kihara M, et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 2003, 14(4):339-346. 10.1023/A:1023956201228, 12846365.
20. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 2003, 32(1):60-63. 10.1093/ije/dyg001, 12690010.
21. Vineis P, Anttila S, Benhamou S, Spinola M, Hirvonen A, Kiyohara C, Garte SJ, Puntoni R, Rannug A, Strange RC, et al. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis. Carcinogenesis 2007, 28(9):1902-1905. 10.1093/carcin/bgm039, 17307802.
22. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000, 9(1):3-28.
23. Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003, 24(5):875-882. 10.1093/carcin/bgg026, 12771031.
24. Pisani P, Srivatanakul P, Randerson-Moor J, Vipasrinimit S, Lalitwongsa S, Unpunyo P, Bashir S, Bishop DT. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand. Cancer Epidemiol Biomarkers Prev 2006, 15(4):667-674. 10.1158/1055-9965.EPI-05-0667, 16614107.
25. Alexandrie AK, Nyberg F, Warholm M, Rannug A. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev 2004, 13(6):908-914.
26. Cascorbi I, Brockmoller J, Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 1996, 56(21):4965-4969.
27. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 1991, 19(17):4797. 10.1093/nar/19.17.4797, 328759, 1891387.
28. Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations. Ther Drug Monit 2005, 27(6):819-821. 10.1097/01.ftd.0000186914.32038.a0, 16306861.
29. Agundez JA, Martinez C, Ledesma MC, Ladona MG, Ladero JM, Benitez J. Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations. Clin Pharmacol Ther 1994, 55(4):412-417. 10.1038/clpt.1994.50, 7909282.
30. Adams SM, Bosch E, Balaresque PL, Ballereau SJ, Lee AC, Arroyo E, Lopez-Parra AM, Aler M, Grifo MS, Brion M, et al. The genetic legacy of religious diversity and intolerance: paternal lineages of Christians, Jews, and Muslims in the Iberian Peninsula. Am J Hum Genet 2008, 83(6):725-736. 10.1016/j.ajhg.2008.11.007, 2668061,2668061, 19061982.
31. Lucotte G, Gerard N, Mercier G. North African genes in Iberia studied by Y-chromosome DNA haplotype 5. Hum Biol 2001, 73(5):763-769. 10.1353/hub.2001.0066, 11758696.
32. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993, 53(13):2994-2999.
33. Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995, 16(10):2331-2336. 10.1093/carcin/16.10.2331, 7586131.
34. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005, 26(12):2207-2212. 10.1093/carcin/bgi191, 16051642.
35. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama K, Ohkawa A, Baba S, Morris BJ, Tsugane S, et al. Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiol Biomarkers Prev 1998, 7(5):413-417.
36. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control 2005, 16(5):579-585. 10.1007/s10552-004-7842-3, 15986113.
37. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 2008, 639(1-2):1-10.
38. Taioli E, Ford J, Trachman J, Li Y, Demopoulos R, Garte S. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 1998, 19(5):813-817. 10.1093/carcin/19.5.813, 9635868.
39. Gallegos-Arreola MP, Figuera-Villanueva LE, Troyo-Sanroman R, Morgan-Villela G, Puebla-Perez AM, Flores-Marquez MR, Zuniga-Gonzalez GM. CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients. Int J Biol Markers 2008, 23(1):24-30.
40. D'Errico A, Malats N, Vineis P, Boffetta P. Review of studies of selected metabolic polymorphisms and cancer. Metabolic Polymorhisms and Susceptibility to Cancer 1999, IARC Scientific publication No 148. Lyon: International Agency for Research on Cancer, Vienis P, Malats N, Lang M, D'Errico A, Caporaso N, Boffetta P.
41. Shields PG, Caporaso NE, Falk RT, Sugimura H, Trivers GE, Trump BF, Hoover RN, Weston A, Harris CC. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 1993, 2(5):481-485.
42. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev 1992, 1(6):485-489.
43. Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, et al. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003, 104(5):650-657. 10.1002/ijc.10995, 12594823.
44. Gervasini G, San Jose C, Carrillo JA, Benitez J, Cabanillas A. GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high incidence area. Nutr Cancer 2010,